Abstract
Introduction

Slowly progressive insulin-dependent diabetes mellitus (SPIDDM) is a disease in which diabetes mellitus, after an initial non-insulin-dependent stage, progresses to an insulindependent stage as a result of a gradual decrease in insulin secretion from the pancreas (1). Because of the presence of autoantibodies directed against the islets of Langerhans
A laboratory examination revealed a fasting plasma glu- (27) (1, 29) . Also, SPIDDM is associated with class II major histocompatibility complex antigens ( HLA-DR 4-DQA 1 * 0301-DQB 1 * 0401 haplotype) (1) . Unfortunately, in the present case, due to financial considerations a detailed DNA analysis was not undertaken. Moreover, the relation between pernicious anemia and HLA differs among reports from foreign countries, so a specific gene locus has not been identified (30) . We expect that a specific gene locus common to pernicious anemia and HLA will be identified once further cases are accumulated.
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Discussion
Polyglandular autoimmune syndrome (PGAS) is characterized by disorders of multiple endocrine and nonendocrine systems that are mediated by autoimmune mechanisms (2). Because of the absence of autoimmune thyroid disease in the present case, the presence of SPIDDM and pernicious anemia in our present patient was not considered to be consistent with a diagnosis of PGAS type III. The occurrence of type 1 diabetes associated with pernicious anemia is uncommon in Japan (about 0.2%), compared with the incidence in Europe and America (about 3.2%) (3). Among a total of 23 reports
. A high titer of anti-GAD antibodies is a common feature and is often accompanied by autoimmune disease (28). The reason for this finding has yet to be elucidated, but GAD is expressed in susceptible tissues such as pancreatic B cells and gastric parietal cells; thus, the possibility of provoked autoimmune reactions and the involvement of the HLA-DRB1 genotype (present in our case) has been suggested
Insulin treatment is highly effective for SPIDDM patients with elevated GAD Ab titers (10 U/mL), and preserving β-cell function prevents progression from a non-insulindependent state to total diabetes associated with the complete cessation of insulin secretion (31) . In the present our case, we started the patient on insulin injections because of the markedly extremely high titer (2,680 U/mL) of GAD Ab. Previous reports published over the last 11 years have suggested that the only insulin that prevents SPIDDM is NPH (32, 33, 34) . According to one report, compared with insulin NPH administered before bedtime, significantly superior 24-hour glycemic control and control of nocturnal hypoglycemia can be obtained using insulin detemir (35 
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